Search

everythinglearnresearchcommunity

for

Search:↓

Zinc supplements increased zinc levels in some hair loss patients but didn't significantly improve hair growth.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

The guide explains how to study human and mouse sebaceous glands using various staining and imaging techniques, and emphasizes the need for standardized assessment methods.

DHT, a testosterone byproduct, causes male pattern baldness.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Hair analysis can reveal metabolic changes and potential pregnancy complications.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

A systematic approach is crucial for managing hair loss in women.

Hormonal therapies are safe and effective for treating adult women's acne.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Iron deficiency is not a significant cause of hair loss in women.

Trichoscan is a reliable method for measuring hair growth and monitoring treatment effectiveness in hair loss.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Finasteride may help some women with hair loss, but better options exist.

The Cross-section Trichometer is a new tool that can measure hair quantity and detect hair loss and growth.

Dogs could be good models for studying human hair growth and hair loss.

A gene deletion causes the "hairless" trait in Iffa Credo rats.

Immune cells affect hair growth and could lead to new hair loss treatments.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.